For decades, the industry has organized itself around a single question: how do we discover more, and better, drug candidates? Target identification keeps getting smarter, molecule generation keeps getting faster, and AI has now touched nearly every stage of early discovery. Yet a molecule is only
Read More
The Next Competitive Advantage in Drug Development Won’t Be a Better Molecule. It’ll Be Better Patient Selection.



























































